Cargando…
Down-regulation of transforming growth factor beta-2 expression is associated with the reduction of cyclosporin induced gingival overgrowth in rats treated with roxithromycin: an experimental study
BACKGROUND: Gingival overgrowth (GO) is a common side effect of the chronic use of cyclosporine (CsA), an immunosuppressant widely used to prevent rejection in transplant patients. Recent studies have reported elevated levels of specific cytokines in gingival overgrowth tissue, particularly TGF-beta...
Autores principales: | Condé, Simone Aparecida Probst, Bastos, Marcus Gomes, Vieira, Beatriz Julião, Aarestrup, Fernando Monteiro |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2802586/ https://www.ncbi.nlm.nih.gov/pubmed/19995419 http://dx.doi.org/10.1186/1472-6831-9-33 |
Ejemplares similares
-
Myofibroblasts and Transforming Growth Factor-Beta1 in Reactive Gingival Overgrowths
por: Epivatianos, Apostolos, et al.
Publicado: (2013) -
Drug-Induced Gingival Overgrowth: The Effect of Cyclosporin A and Mycophenolate Mophetil on Human Gingival Fibroblasts
por: Lauritano, Dorina, et al.
Publicado: (2020) -
Cyclosporine A: Novel concepts in its role in drug-induced gingival overgrowth
por: Ponnaiyan, Deepa, et al.
Publicado: (2015) -
Periodontal Management of Cyclosporin A-Induced Gingival Overgrowth: A Nonsurgical Approach
por: Malek, Rayhana, et al.
Publicado: (2019) -
Medical Management of Cyclosporine-Induced Gingival Overgrowth Using Oral Azithromycin in Six Dogs
por: Diesel, Alison, et al.
Publicado: (2015)